Personalised multi-drug therapy guided by tumour DNA improves outcomes
Precision oncology has traditionally focused on matching single drugs to single molecular alterations. However, most…
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Precision oncology has traditionally focused on matching single drugs to single molecular alterations. However, most…
Assessing response to immunotherapy remains challenging, particularly early in treatment when radiographic changes can be…
Metastatic triple-negative breast cancer (TNBC) remains one of the most difficult breast cancer subtypes to…
A new study shows that cancer damages its own DNA by pushing key genes to…
In breast cancer, a biopsy is the only diagnostic procedure that can determine if a…
Spinal metastasis, the spread of cancer to the spine, is a frequent complication in advanced…
Recognising the sight of blood in urine, the most common first sign of bladder cancer,…
A preclinical study published in Molecular Therapy Oncology has shown that CRISPR-Cas9 gene editing can…
Leading genomic health experts from Monash University are calling for urgent government funding to progress…
New research from a regional Australian cancer centre has assessed the practical utility of molecular…